tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 75 are a BUY (82.42%), 16 are a HOLD (17.58%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 54.31% that have a potential upside of 51.13% achieved within 326 days. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 182 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2023
$124
$42.15 (51.50%)
$115
21 days ago
(16-Jan-2026)
10/13 (76.92%)
$38.71 (45.39%)
291
Buy Since 10-Jul-2025
$121
$39.15 (47.83%)
$84
4 months 20 days ago
(17-Sep-2025)
4/5 (80%)
$25.64 (26.89%)
671
Hold Since 11-Sep-2024
$77
$-4.85 (-5.93%)
$65
5 months 26 days ago
(11-Aug-2025)
11/11 (100%)
$-7.88 (-9.28%)
352
Buy Since 07-Sep-2022
$94
$12.15 (14.84%)
$94
10 months 20 days ago
(17-Mar-2025)
13/13 (100%)
$29.65 (46.08%)
317
Buy Since 28-Feb-2019
$83
$1.15 (1.41%)
$49
1 years 4 months 19 days ago
(18-Sep-2024)
12/12 (100%)
$21.95 (35.95%)
597
What Year was the first public recommendation made by Scott Henry?
